» Articles » PMID: 22766954

Coplanar Versus Noncoplanar Intensity-modulated Radiation Therapy (IMRT) and Volumetric-modulated Arc Therapy (VMAT) Treatment Planning for Fronto-temporal High-grade Glioma

Overview
Date 2012 Jul 7
PMID 22766954
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to compare dosimetric and radiobiological parameters of treatment plans using coplanar and noncoplanar beam arrangements in patients with fronto-temporal high-grade glioma (HGG) generated for intensity-modulated radiotherapy (IMRT) or volumetric-modulated arc therapy (VMAT). Ten cases of HGG overlapping the optic apparatus were selected. Four separate plans were created for each case: coplanar IMRT, noncoplanar IMRT (ncIMRT), VMAT, and noncoplanar VMAT (ncVMAT). The prescription dose was 60 Gy in 30 fractions. Dose-volume histograms and equivalent uniform doses (EUD) for planning target volumes (PTVs) and organs at risk (OARs) were generated. The four techniques resulted in comparable mean, minimum, maximum PTV doses, and PTV EUDs (p ≥ 0.33). The mean PTV dose and EUD averaged for all techniques were 59.98 Gy (Standard Deviation (SD) ± 0.15) and 59.86 Gy (SD ± 0.27). Non-coplanar IMRT significantly reduced contralateral anterior globe EUDs (6.7 Gy versus 8.2 Gy, p = 0.05), while both ncIMRT and ncVMAT reduced contralateral retina EUDs (16 Gy versus 18.8 Gy, p = 0.03). Noncoplanar techniques resulted in lower contralateral temporal lobe dose (22.2 Gy versus 24.7 Gy). Compared to IMRT, VMAT techniques required fewer monitor units (755 vs. 478, p ≤ 0.001) but longer optimization times. Treatment delivery times were 6.1 and 10.5 minutes for coplanar and ncIMRT versus 2.9 and 5.0 minutes for coplanar and ncVMAT. In this study, all techniques achieved comparable target coverage. Superior sparing of contralateral optic structures was seen with ncIMRT. The VMAT techniques reduced treatment delivery duration but prolonged plan optimization times, compared to IMRT techniques. Technique selection should be individualized, based on patient-specific clinical and dosimetric parameters.

Citing Articles

A Dosimetric Comparison of HyperArc Therapy Planning and Volumetric Modulated Arc Therapy Planning in Treating Patients With Glioblastoma Multiforme.

Hong W, Ho H, Lin H, Lin T, Chow W, Yang C In Vivo. 2025; 39(2):1009-1021.

PMID: 40011001 PMC: 11884473. DOI: 10.21873/invivo.13906.


Benchmarking MapRT and first clinical experience: A novel solution for collision-free non-coplanar treatment planning.

Gonod M, Achag I, Farah J, Aubignac L, Bessieres I J Appl Clin Med Phys. 2025; 26(3):e14572.

PMID: 39907187 PMC: 11905235. DOI: 10.1002/acm2.14572.


Exploring feasibility criteria for stereotactic radiosurgical treatment of multiple brain metastases using five linac machines.

Sakai Y, Kubo K, Monzen H, Ueda Y, Tanooka M, Miyazaki M J Appl Clin Med Phys. 2024; 25(9):e14413.

PMID: 38923786 PMC: 11492394. DOI: 10.1002/acm2.14413.


HyperArcTM volumetric modulated arc therapy for hypopharyngeal cancer with solitary recurrence in the cervical vertebra: A case report and literature review.

Lin C, Que J, Ho S Medicine (Baltimore). 2024; 103(23):e38427.

PMID: 38847726 PMC: 11155512. DOI: 10.1097/MD.0000000000038427.


Dosimetric Comparision of Coplanar versus Noncoplanar Volumetric Modulated Arc Therapy for Treatment of Bilateral Breast Cancers.

Bharati A, Rath S, Khurana R, Rastogi M, Mandal S, Gandhi A J Med Phys. 2023; 48(3):252-258.

PMID: 37969151 PMC: 10642589. DOI: 10.4103/jmp.jmp_36_23.


References
1.
Sharma S, Jalali R, Phurailatpam R, Gupta T . Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours?. Clin Oncol (R Coll Radiol). 2009; 21(5):408-16. DOI: 10.1016/j.clon.2009.02.002. View

2.
Amelio D, Lorentini S, Schwarz M, Amichetti M . Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. Radiother Oncol. 2010; 97(3):361-9. DOI: 10.1016/j.radonc.2010.08.018. View

3.
Hegi M, Diserens A, Gorlia T, Hamou M, De Tribolet N, Weller M . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003. DOI: 10.1056/NEJMoa043331. View

4.
Popescu C, Olivotto I, Beckham W, Ansbacher W, Zavgorodni S, Shaffer R . Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys. 2009; 76(1):287-95. DOI: 10.1016/j.ijrobp.2009.05.038. View

5.
MacDonald S, Ahmad S, Kachris S, Vogds B, DeRouen M, Gittleman A . Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison. J Appl Clin Med Phys. 2007; 8(2):47-60. PMC: 5722415. DOI: 10.1120/jacmp.v8i2.2423. View